Re: Joint meeting for Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSARM AC), September 17, 2014

J Urol. 2015 Feb;193(2):623-5. doi: 10.1016/j.juro.2014.11.060. Epub 2014 Nov 15.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Advisory Committees
  • Androgens / therapeutic use*
  • Congresses as Topic
  • Hormone Replacement Therapy / adverse effects
  • Hormone Replacement Therapy / standards*
  • Humans
  • Hypogonadism / drug therapy*
  • Male
  • Risk Management
  • Testosterone / therapeutic use*
  • United States
  • United States Food and Drug Administration*

Substances

  • Androgens
  • Testosterone